AU2021358074A1 - Acetamido-phenyltetrazole derivatives and methods of using the same - Google Patents
Acetamido-phenyltetrazole derivatives and methods of using the same Download PDFInfo
- Publication number
- AU2021358074A1 AU2021358074A1 AU2021358074A AU2021358074A AU2021358074A1 AU 2021358074 A1 AU2021358074 A1 AU 2021358074A1 AU 2021358074 A AU2021358074 A AU 2021358074A AU 2021358074 A AU2021358074 A AU 2021358074A AU 2021358074 A1 AU2021358074 A1 AU 2021358074A1
- Authority
- AU
- Australia
- Prior art keywords
- heteroatoms selected
- alkyl
- membered
- heterocyclyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063088788P | 2020-10-07 | 2020-10-07 | |
| US63/088,788 | 2020-10-07 | ||
| PCT/US2021/053937 WO2022076663A1 (en) | 2020-10-07 | 2021-10-07 | Acetamido-phenyltetrazole derivatives and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021358074A1 true AU2021358074A1 (en) | 2023-04-27 |
Family
ID=78483546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021358074A Pending AU2021358074A1 (en) | 2020-10-07 | 2021-10-07 | Acetamido-phenyltetrazole derivatives and methods of using the same |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11739089B2 (https=) |
| EP (1) | EP4225747A1 (https=) |
| JP (1) | JP7823036B2 (https=) |
| KR (1) | KR20230104151A (https=) |
| CN (1) | CN116964044B (https=) |
| AU (1) | AU2021358074A1 (https=) |
| CA (1) | CA3194694A1 (https=) |
| IL (1) | IL301516A (https=) |
| MX (1) | MX2023003933A (https=) |
| TW (1) | TWI900672B (https=) |
| WO (1) | WO2022076663A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| CN110312130B (zh) * | 2019-06-25 | 2021-10-15 | 浙江大华技术股份有限公司 | 基于三角模式的帧间预测、视频编码方法及设备 |
| TWI900672B (zh) | 2020-10-07 | 2025-10-11 | 香港商希華醫藥有限公司 | 乙醯胺基－苯基四唑衍生物及其使用方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5663179A (en) | 1992-07-10 | 1997-09-02 | Laboratoires Glaxo Sa | Certain isoquinoline derivatives having anti-tumor properties |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| GB9717576D0 (en) | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
| KR100557093B1 (ko) * | 2003-10-07 | 2006-03-03 | 한미약품 주식회사 | 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법 |
| KR101466245B1 (ko) * | 2010-01-15 | 2014-12-01 | 한미사이언스 주식회사 | 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물 |
| KR101986683B1 (ko) | 2012-12-13 | 2019-06-10 | 한미약품 주식회사 | 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체 |
| WO2015152433A1 (en) | 2014-03-31 | 2015-10-08 | Hanmi Pharm. Co., Ltd. | Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same |
| KR102293907B1 (ko) | 2015-06-30 | 2021-08-26 | 한미약품 주식회사 | 이리노테칸 함유 경구용 고형제제 및 그 제조방법 |
| TWI838700B (zh) | 2015-09-30 | 2024-04-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
| TWI833710B (zh) | 2017-10-06 | 2024-03-01 | 香港商慧源香港創新有限公司 | 高單位含量口服型紫杉烷組合物及方法 |
| TWI900672B (zh) | 2020-10-07 | 2025-10-11 | 香港商希華醫藥有限公司 | 乙醯胺基－苯基四唑衍生物及其使用方法 |
-
2021
- 2021-10-07 TW TW110137339A patent/TWI900672B/zh active
- 2021-10-07 US US17/495,935 patent/US11739089B2/en active Active
- 2021-10-07 AU AU2021358074A patent/AU2021358074A1/en active Pending
- 2021-10-07 MX MX2023003933A patent/MX2023003933A/es unknown
- 2021-10-07 CA CA3194694A patent/CA3194694A1/en active Pending
- 2021-10-07 WO PCT/US2021/053937 patent/WO2022076663A1/en not_active Ceased
- 2021-10-07 KR KR1020237015140A patent/KR20230104151A/ko active Pending
- 2021-10-07 EP EP21801761.4A patent/EP4225747A1/en active Pending
- 2021-10-07 JP JP2023521299A patent/JP7823036B2/ja active Active
- 2021-10-07 CN CN202180079852.2A patent/CN116964044B/zh active Active
- 2021-10-07 IL IL301516A patent/IL301516A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230104151A (ko) | 2023-07-07 |
| MX2023003933A (es) | 2023-07-05 |
| EP4225747A1 (en) | 2023-08-16 |
| US11739089B2 (en) | 2023-08-29 |
| WO2022076663A1 (en) | 2022-04-14 |
| CN116964044A (zh) | 2023-10-27 |
| IL301516A (en) | 2023-05-01 |
| CA3194694A1 (en) | 2022-04-14 |
| JP2023544615A (ja) | 2023-10-24 |
| TW202233593A (zh) | 2022-09-01 |
| TWI900672B (zh) | 2025-10-11 |
| CN116964044B (zh) | 2026-03-06 |
| JP7823036B2 (ja) | 2026-03-03 |
| US20220106312A1 (en) | 2022-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018311198B2 (en) | Selective inhibitors of NLRP3 inflammasome | |
| EP3555070B1 (en) | Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof | |
| JP2021193131A (ja) | Ｒｏｒ−ガンマのモジュレータとしてのベンズイミダゾール誘導体 | |
| WO2022051596A1 (en) | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | |
| US20050171101A1 (en) | Phenanthridinones as parp inhibitors | |
| US11739089B2 (en) | Acetamido-phenyltetrazole derivatives and methods of using the same | |
| KR20220141331A (ko) | P2x3 조정제 | |
| WO2024026419A1 (en) | Quinoxaline derivatives as pik3 alpha modulators | |
| WO2024026424A1 (en) | Quinazolinone derivatives as and related uses | |
| WO2022147302A1 (en) | 4-phenyl-indole derivatives and related uses | |
| WO2024026423A1 (en) | Substituted quinoline derivatives as pi3k inhibitors | |
| WO2022266425A1 (en) | 3-cyano-quinoline derivatives and uses thereof | |
| EP4225745A1 (en) | Acetamido-phenylbenzamide derivatives and methods of using the same | |
| WO2022266427A1 (en) | 4-(aryl-methyl-amino)-quinazoline derivatives and uses thereof | |
| EP4724426A1 (en) | Statin derivatives and methods of using the same | |
| TW202334097A (zh) | 用於治療癌症之苯并【ｈ】喹唑啉－４－胺衍生物 | |
| AU687414B2 (en) | Piperidinyl substituted methanoanthracenes as D1/D2-antagonists and 5HT2-serotanin-antagonists | |
| JP2024537311A (ja) | Ｓｈｐ２阻害剤、それを含む医薬組成物およびその使用 | |
| OA19666A (en) | Amine-substituted heterocyclic compounds as Ehmt2 inhibitors and methods of use thereof. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: HEALTH HOPE PHARMA HK LIMITED Free format text: FORMER APPLICANT(S): ATHENEX, INC. |